The transplant programs at Stanford Health Care have earned a number of distinctions, including outstanding outcomes for both patient and graft survival. We have long been at the forefront in the field of transplantation and home to both the first adult heart transplant in the US and the first heart-lung transplant in the world.
From careful pre-transplant monitoring to post-surgical care, our strong emphasis on continuous quality improvement creates better outcomes for transplant patients. We also maintain comprehensive outpatient management of transplant recipients that includes infection prophylaxis, management of immunosuppression, and long-term patient monitoring and care.
Our multidisciplinary transplant teams are comprised of surgeons, medical specialists, nurse coordinators, social workers and ancillary staff members who provide superior, specialized expertise in all related transplant services.
Robert Negrin, MD, Director of Stanford's Blood and Marrow Transplant program on why he left biochemistry to become a hematologist.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care (formerly Stanford Hospital & Clinics) provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.
Track your patients' progress and communicate with Stanford providers securely online.